Guidelines for Complications of Cancer Treatment Vol VIII Part B

8. Eisbruch A, Kim HM, Terrell JE, Marsh LH, DawsonLA, Ship JA. Xerostomia and its predictors followingparotidsparing irradiation of head-and-neck cancer. IntJ Radiat Oncol Biol Phys 2001;50:695–704.9. Eisbruch A, Ship JA, Dawson LA, Kim HM, BradfordCR, Terrell JE, et al. Salivary gland sparing and improvedtarget irradiation by conformal and intensity modulatedirradiation of head and neck cancer. World J Surg2003;27(7):832-7.10. Eisbruch A.Reducing xerostomia by IMRT: what may,and may not, be achieved. J Clin Oncol. 2007 Nov1;25(31):4863-4. No abstract available.11. Gornitsky M, Shenouda G, Sultanem K, Katz H, HierM, Black M, et al. Double-blind randomized, placebocontrolledstudy of pilocarpine to salvage salivary glandfunction during radiotherapy of patients with head andneck cancer. Oral Surg Oral Med Oral Pathol Oral RadiolEndod 2004;98(1):45-52.12. Guchelaar HJ, Vermes A, Meerwaldt JH. Radiationinducedxerostomia: pathophysiology, clinical courseand supportive treatment. Support Care Cancer1997;5(4):281-8.13. Jellema AP, Langendijk H, Bergenhenegouwen L, etal.The efficacy of Xialine in patients with xerostomiaresulting from radiotherapy for head and neck cancer: apilot-study. Radiother Oncol 2001;59:157–160.14. Jha N, Seikaly H, Harris J, Williams D, Liu R, McGawT, et al. Prevention of radiation induced xerostomia bysurgical transfer of submandibular salivary gland intothe submental space. Radiother Oncol 2003;66(3):283-9.15. Johnson JT, Ferretti GA, Nethery WJ, et al. Oralpilocarpine for post-irradiation xerostomia in patients174